Shinobu Shibata
Tohoku University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shinobu Shibata.
Annals of the Rheumatic Diseases | 1999
Chihiro Murai; Yasuhiko Munakata; Yuichi Takahashi; Tomonori Ishii; Shinobu Shibata; Tai Muryoi; Tadao Funato; Masataka Nakamura; Kazuo Sugamura; Takeshi Sasaki
Polyarthropathy associated with human parvovirus B19 (B19) is usually transient, but often resembles rheumatoid arthritis (RA).1-3 However, B19 DNA screened by polymerase chain reaction (PCR) may be positive not only in autoimmune diseases, but also in non-arthropathy.4 To study whether or not RA occurs after acute B19 infection, we conducted a prospective study of patients with acute onset polyarthritis. Sixty seven cases showing acute inflammatory polyarthritis from January 1990 to June 1990 were examined and followed up for six years. Among them, 12 (9 female and 3 male) exhibited IgM anti-B19 antibodies.5 PCR, followed by a Southern blot analysis6 also showed the presence of B19 DNA in all 12 cases with IgM anti-B19 antibodies, but did not in the remainder. Initially, rheumatoid factor (RF) was negative in all B19 positive cases except one, but became positive in four, two to four months after the infection (table 1). Among RF …
Microbiology and Immunology | 1993
Toshiaki Ohteki; Toru Abo; Akinori Kusumi; Takeshi Sasaki; Shinobu Shibata; Shuhji Seki; Katsuo Kumagai
The liver has been demonstrated to be a major site for extrathymic differentiation of T cells. In this study, an identification of CD5+ B cells, which are responsible for the onset of autoimmune disease by virtue of autoantibody production, was performed in autoimmune (NZB × NZW) F1 mice. An age‐associated increase of CD5+ B cells was demonstrated in the liver of these mice. Although CD5+ B cells (i.e., CD5+IgM+ and CD5+B220+) constituted a minor population of hepatic mononuclear cells (MNC) (<5%) when mice were young (8 weeks), a large population of CD5+ B cells (10 to 30% of whole MNC) was identified in the liver of mice aged 25 to 30 weeks after the onset of disease. Such age‐dependent increase of CD5+ B cells was not observed in any other strains including NZB, NZW, C3H/He and BALB/c mice. The phenotype of hepatic CD5+ B cells was the same as that of CD5+ B cells in the peritoneal cavity and spleen, showing dull‐CD5, bright‐IgM and dull‐B220. High levels of CD5+ B cells were observed in the peritoneal cavity and liver, but not in the spleen nor in any other lymphoid organs in mice aged 30 weeks. Radioimmunoassay of autoantibodies in the 5‐day culture supernatants demonstrated that hepatic MNC were unable to produce any amounts of IgM‐ and IgG‐autoantibodies against double‐stranded DNA and single‐stranded DNA, despite the increased proportion of CD5+ B cells. On the other hand, peritoneal exudate cells produced only IgM‐, but not IgG‐, autoantibodies, whereas splenic cells were able to produce both IgM‐ and IgG‐autoantibodies. These results suggest that the liver might support the generation of the most primitive CD5+ B cells in these mice and that such generation increases as a function of age, probably resulting in the onset of autoimmune disease.
Clinical Immunology and Immunopathology | 1992
Shinobu Shibata; Takeshi Sasaki; Akira Hatakeyama; Yasuhiko Munakata; Yasuhiko Hirabayashi; Kaoru Yoshinaga
In order to identify the mechanism responsible for autoantibody production in systemic lupus erythematosus (SLE), B cell repertoires associated with anti-DNA idiotypes were explored by a limiting dilution analysis using Epstein-Barr virus (EBV) transformation methods and ELISA spot assays. The frequencies of B cell clones producing antibodies to DNA and to conventional antigens, tetanus toxoid, dinitrophenyl, or keyhole limpet hemocyanin were higher in active SLE compared to those in inactive SLE and in normal subjects. In addition, there was a disproportionate increase in anti-DNA antibody- and anti-DNA idiotype (Id)-producing clones at the precursor cell levels as well as at the mature cell level. On the other hand, numbers of anti-Id clones against anti-DNA-Id, termed 0-81 Id, were markedly increased at inactive stages of the disease but not at active stages. These were confirmed by serial studies in some patients with SLE. These results support a two-step mechanism for autoantibody production, in which initial polyclonal activation is followed by an antigen-driven process, and indicate an alteration of the precursor B cell repertoire in SLE, which may also associate with a preferential expansion of anti-DNA clones.
European Journal of Immunology | 1998
Yasuhiko Munakata; Shinichiro Saito; Atsushi Hoshino; Tai Muryoi; Yasuhiko Hirabayashi; Shinobu Shibata; Toshihiko Miura; Tomonori Ishii; Tadao Funato; Takeshi Sasaki
Naive B cells expressing IgM and IgD on their surface have no or little somatic mutations in V genes. We have demonstrated that the human IgM+IgD+B cell clone (0 – 81), which expresses nephritogenic idiotypes, produces IgM anti‐DNA antibodies which show monospecificity to DNA. Using a DNA probe which specifically links to the VH gene of antibody 0 – 81, we identified the counterpart germ‐line V gene of 0 – 81, V3‐7, which appears to be used by pathogenic autoantibodies in humans. Clone 0 – 81, which may belong to naive B cells in terms of cell phenotype, uses a somatically mutated V3‐7 gene. We further studied DNA sequences of V3‐7 genes in circulating IgM+IgD+B cells from normal subjects and patients with systemic lupus erythematosus (SLE). The results revealed that rearranged V3‐7 genes in IgM+IgD+B cells from patients with SLE contained somatically mutated sequences at significantly increased frequencies. These data indicate an abnormal maturation of B cells in autoimmune states that may be associated with an escape of self‐reactive B cells from the elimination process in the germinal center.
Proceedings of the National Academy of Sciences of the United States of America | 1998
Yuichi Takahashi; Chihiro Murai; Shinobu Shibata; Yasuhiko Munakata; Tomonori Ishii; Keiko Ishii; Takako Saitoh; Takashi Sawai; Kazuo Sugamura; Takeshi Sasaki
Clinical Immunology and Immunopathology | 1994
Shinobu Shibata; Takashi Sasaki; Peter C. Harpel; Howard Fillit
Thrombosis and Haemostasis | 2000
Yasuhiko Munakata; Takako Saito; Kumiko Matsuda; Jin Seino; Shinobu Shibata; Takeshi Sasaki
Journal of Immunology | 1990
Tai Muryoi; Takeshi Sasaki; Akira Hatakeyama; Shinobu Shibata; Misao Suzuki; J Seino; Kaoru Yoshinaga
Kidney International | 1991
Takeshi Sasaki; Akira Hatakeyama; Shinobu Shibata; Hirofumi Osaki; Masahiko Suzuki; Katuyuki Horie; Yoshichika Kitagawa; Kaoru Yoshinaga
The Lancet | 1989
Chihiro Murai; Takeshi Sasaki; Hirohumi Osaki; Akira Hatakeyama; Shinobu Shibata; Kaoru Yoshinaga